Literature DB >> 18625709

ATR-dependent activation of p38 MAP kinase is responsible for apoptotic cell death in cells depleted of Cdc7.

Jun-Sub Im1, Joon-Kyu Lee.   

Abstract

Cdc7 is a serine/threonine kinase that plays essential roles in the initiation of eukaryotic DNA replication and checkpoint response. In previous studies, depletion of Cdc7 by small interfering RNA was shown to induce an abortive S phase that led to the cell cycle arrest in normal human fibroblasts and apoptotic cell death in various cancer cells. Here we report that stress-activated p38 MAP kinase was activated and responsible for apoptotic cell death in Cdc7-depleted HeLa cells. The activation of p38 MAP kinase in the Cdc7-depleted cells was shown to depend on ATR, a major sensor kinase for checkpoint or DNA damage responses. Only the p38 MAP kinase, and not the other stress-activated kinases such as JNK or ERK, was activated, and both caspase 8 and caspase 9 were activated for the induction of apoptosis. Activation of apoptosis in Cdc7-depleted cells was completely abolished in cells treated with small interfering RNA or an inhibitor of the p38 MAP kinase, suggesting that p38 MAP kinase activation was responsible for apoptotic cell death. Taken together, we suggest that the ATR-dependent activation of the p38 MAP kinase is a major signaling pathway that induces apoptotic cell death after depletion of Cdc7 in cancer cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18625709     DOI: 10.1074/jbc.M802851200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  A role for Chk1 in blocking transcriptional elongation of p21 RNA during the S-phase checkpoint.

Authors:  Rachel Beckerman; Aaron J Donner; Melissa Mattia; Melissa J Peart; James L Manley; Joaquin M Espinosa; Carol Prives
Journal:  Genes Dev       Date:  2009-06-01       Impact factor: 11.361

2.  Effects of CDC7 gene silencing and Rituximab on apoptosis in diffuse large B cell lymphoma cells.

Authors:  Yun Hou; Hua-Qing Wang; Yi Ba
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-18       Impact factor: 4.553

3.  Mechanical impact induces cartilage degradation via mitogen activated protein kinases.

Authors:  L Ding; E Heying; N Nicholson; N J Stroud; G A Homandberg; J A Buckwalter; D Guo; J A Martin
Journal:  Osteoarthritis Cartilage       Date:  2010-09-09       Impact factor: 6.576

4.  CDKN2A/p16 Deletion in Head and Neck Cancer Cells Is Associated with CDK2 Activation, Replication Stress, and Vulnerability to CHK1 Inhibition.

Authors:  Mitchell J Frederick; Jeffrey N Myers; Mayur A Gadhikar; Jiexin Zhang; Li Shen; Xiayu Rao; Jing Wang; Mei Zhao; Nene N Kalu; Faye M Johnson; Lauren A Byers; John Heymach; Walter N Hittelman; Durga Udayakumar; Raj K Pandita; Tej K Pandita; Curtis R Pickering; Abena B Redwood; Helen Piwnica-Worms; Katharina Schlacher
Journal:  Cancer Res       Date:  2017-12-11       Impact factor: 12.701

Review 5.  p38α MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance.

Authors:  Valentina Grossi; Alessia Peserico; Tugsan Tezil; Cristiano Simone
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

6.  Three-dimensional quantitative structure-activity relationships of pyrrolopyridinone as cell division cycle kinase inhibitors by CoMFA and CoMSIA.

Authors:  Junxia Zheng; Gaokeng Xiao; Jialiang Guo; Longyi Rao; Wei Chao; Kun Zhang; Pinghua Sun
Journal:  J Mol Model       Date:  2011-03-18       Impact factor: 1.810

7.  Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation, leading to aneuploidy in human mammary epithelial cells.

Authors:  Lauren Gardner; Rohit Malik; Yoshiko Shimizu; Nicole Mullins; Wael M ElShamy
Journal:  Breast Cancer Res       Date:  2011-05-19       Impact factor: 6.466

8.  Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancer.

Authors:  Nathaniel Melling; Johanna Muth; Ronald Simon; Carsten Bokemeyer; Luigi Terracciano; Guido Sauter; Jakob Robert Izbicki; Andreas Holger Marx
Journal:  Diagn Pathol       Date:  2015-07-25       Impact factor: 2.644

9.  Drug design with Cdc7 kinase: a potential novel cancer therapy target.

Authors:  Masaaki Sawa; Hisao Masai
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

10.  Mechanism of cancer cell death induced by depletion of an essential replication regulator.

Authors:  Sayuri Ito; Ai Ishii; Naoko Kakusho; Chika Taniyama; Satoshi Yamazaki; Rino Fukatsu; Asako Sakaue-Sawano; Atsushi Miyawaki; Hisao Masai
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.